BioSpace News Archive

Business

Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Edwin Beale as its new Chief Commercial Officer, effective immediately.

March 12, 2024
·
2 min read
Genetown

Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease

Prilenia Therapeutics B.V. announced its plan to submit a Marketing Authorization Application (MAA) for pridopidine for the treatment of Huntington’s disease (HD) to the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).

March 12, 2024
·
5 min read
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level.

March 12, 2024
·
4 min read
Deals

Innovaccer Announces Acquisition of Pharmacy Quality Solutions to Accelerate Value-Based Care in Pharmacy Settings

Innovaccer, a leading healthcare company, has announced the completion of its acquisition of Pharmacy Quality Solutions, a leader in Pharmacy-Payer performance technology.

March 12, 2024
·
4 min read
BioCapital

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced today that management will participate in a fireside chat as part of the Stifel 2024 CNS Days on Tuesday, March 19, 2024, at 12:00 p.m. ET.

March 12, 2024
·
1 min read
Business

iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results

iCAD, Inc. (NASDAQ: ICAD) today announced results for its fiscal fourth quarter and full year ended December 31, 2023, as compared to the corresponding period of the last fiscal year.

March 12, 2024
·
21 min read
Biotech Beach

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

Inari Medical, Inc. a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive two-year interim results from the CLOUT registry.

March 12, 2024
·
3 min read
Business

Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2023 and highlighted recent corporate updates.

March 12, 2024
·
16 min read
Business

Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates

Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported full year 2023 financial results.

March 12, 2024
·
12 min read
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a virtual R&D Day, Tuesday, March 19, from 8:00 a.m. to 10:00 a.m. ET, focused on zanidatamab, a differentiated, bispecific antibody in late-stage development with the potential to transform the standard of care in multiple HER2-positive cancers.

March 12, 2024
·
2 min read